<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Pharma — Juli 2023]]></title><description><![CDATA[<p dir="auto">Sandoz To Launch Hyrimoz High-concentration Formulation <a href="https://www.proinvestor.com/investornyt/1008962/sandoz-to-launch-hyrimoz-high-concentration-formulation" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1008962/sandoz-to-launch-hyrimoz-high-concentration-formulation</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400876/pharma-juli-2023</link><generator>RSS for Node</generator><lastBuildDate>Sun, 07 Jun 2026 04:31:47 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400876.rss" rel="self" type="application/rss+xml"/><pubDate>Sun, 02 Jul 2023 02:57:45 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Pharma — Juli 2023 on Mon, 31 Jul 2023 07:06:59 GMT]]></title><description><![CDATA[<p dir="auto">Biotech Stocks Facing FDA Decision In August 2023 <a href="https://www.proinvestor.com/investornyt/1024285/biotech-stocks-facing-fda-decision-in-august-2023" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1024285/biotech-stocks-facing-fda-decision-in-august-2023</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037883</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037883</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 31 Jul 2023 07:06:59 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Mon, 31 Jul 2023 03:25:38 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037882</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037882</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Mon, 31 Jul 2023 03:25:38 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Sun, 30 Jul 2023 10:55:16 GMT]]></title><description><![CDATA[<p dir="auto">The Top Healthcare Stocks to Buy With $100 <a href="https://www.proinvestor.com/investornyt/1024104/the-top-healthcare-stocks-to-buy-with-100" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1024104/the-top-healthcare-stocks-to-buy-with-100</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037878</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037878</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Sun, 30 Jul 2023 10:55:16 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Sun, 30 Jul 2023 03:20:35 GMT]]></title><description><![CDATA[<p dir="auto">Is GSK Stock Worth Buying Right Now? <a href="https://www.proinvestor.com/investornyt/1024057/is-gsk-stock-worth-buying-right-now" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1024057/is-gsk-stock-worth-buying-right-now</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037881</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037881</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Sun, 30 Jul 2023 03:20:35 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Sat, 29 Jul 2023 09:55:39 GMT]]></title><description><![CDATA[<p dir="auto">Piper Sandler Maintains Abbvie (ABBV) Overweight Recommendationhttps://www.proinvestor.com/investornyt/1023913/piper-sandler-maintains-abbvie-abbv-overweight-recommendation</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037879</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037879</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Sat, 29 Jul 2023 09:55:39 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Fri, 28 Jul 2023 17:33:23 GMT]]></title><description><![CDATA[<p dir="auto">AstraZe neca Plc (AZN) Q2 2023 Earnings Call Transcript <a href="https://www.proinvestor.com/investornyt/1023552/astrazeneca-plc-azn-q2-2023-earnings-call-transcript" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1023552/astrazeneca-plc-azn-q2-2023-earnings-call-transcript</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037877</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037877</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Fri, 28 Jul 2023 17:33:23 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Fri, 28 Jul 2023 04:55:09 GMT]]></title><description><![CDATA[<p dir="auto">Medicinalselskabet Bristol-Myers Squibb kunne inden børsåbning vise sløje resultater for andet kvartal samt en nedjustering af forventningerne drevet af et skuffende salg af kræftmidlet Revlimid.<br />
Det blev der kvitteret for med et fald til aktien på 3,8 pct. torsdag.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037874</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037874</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Fri, 28 Jul 2023 04:55:09 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Fri, 28 Jul 2023 04:41:04 GMT]]></title><description><![CDATA[<p dir="auto">Sanofi Q2 Profit Rises, Sales Up 3.3% At CER; Raises 2023 Business EPS Guidance <a href="https://www.proinvestor.com/investornyt/1023041/sanofi-q2-profit-rises-sales-up-33-at-cer-raises-2023-business-eps-guidance" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1023041/sanofi-q2-profit-rises-sales-up-33-at-cer-raises-2023-business-eps-guidance</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037884</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037884</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 28 Jul 2023 04:41:04 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Fri, 28 Jul 2023 03:44:52 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037873</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037873</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Fri, 28 Jul 2023 03:44:52 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Thu, 27 Jul 2023 05:18:04 GMT]]></title><description><![CDATA[<p dir="auto">Japansk Lundbeck-partner leverer over forventning <a href="https://www.proinvestor.com/investornyt/1022171/japansk-lundbeck-partner-leverer-over-forventning" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1022171/japansk-lundbeck-partner-leverer-over-forventning</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037875</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037875</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 27 Jul 2023 05:18:04 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Thu, 27 Jul 2023 03:46:59 GMT]]></title><description><![CDATA[<p dir="auto">Roche tynget af svindende efterspørgsel på coronamidler i første halvår<br />
<a href="https://www.proinvestor.com/investornyt/1022152/roche-tynget-af-svindende-eftersporgsel-pa-coronamidler-i-forste-halvar" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1022152/roche-tynget-af-svindende-eftersporgsel-pa-coronamidler-i-forste-halvar</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037876</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037876</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 27 Jul 2023 03:46:59 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Thu, 27 Jul 2023 03:37:54 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037870</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037870</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Thu, 27 Jul 2023 03:37:54 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Wed, 26 Jul 2023 06:01:54 GMT]]></title><description><![CDATA[<h2>Dagens aktie er Regeneron<br />
Pharmaceuticals Inc.</h2>
<p dir="auto">Regeneron Pharmaceuticals, Inc. er en amerikansk bioteknologivirksomhed der forsker, udvikler, fabrikerer og klargør medicin til markedet <a href="https://proinvestor.com/boards/114238/" rel="nofollow ugc">https://proinvestor.com/boards/114238/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037872</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037872</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 26 Jul 2023 06:01:54 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Wed, 26 Jul 2023 03:28:46 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037880</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037880</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Wed, 26 Jul 2023 03:28:46 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Tue, 25 Jul 2023 03:17:12 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037871</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037871</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Tue, 25 Jul 2023 03:17:12 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Mon, 24 Jul 2023 05:23:31 GMT]]></title><description><![CDATA[<p dir="auto">Sandoz Obtains Positive CHMP Opinion For Multiple Sclerosis Biosimilar Natalizumab <a href="https://www.proinvestor.com/investornyt/1019879/sandoz-obtains-positive-chmp-opinion-for-multiple-sclerosis-biosimilar-natalizumab" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1019879/sandoz-obtains-positive-chmp-opinion-for-multiple-sclerosis-biosimilar-natalizumab</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037865</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037865</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 24 Jul 2023 05:23:31 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Mon, 24 Jul 2023 05:22:51 GMT]]></title><description><![CDATA[<p dir="auto">GSK : ViiV's Cabotegravir For HIV Prevention Receives Positive CHMP Opinion From EMA <a href="https://www.proinvestor.com/investornyt/1019886/gsk-viivs-cabotegravir-for-hiv-prevention-receives-positive-chmp-opinion-from-ema" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1019886/gsk-viivs-cabotegravir-for-hiv-prevention-receives-positive-chmp-opinion-from-ema</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037864</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037864</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 24 Jul 2023 05:22:51 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Sat, 22 Jul 2023 10:19:41 GMT]]></title><description><![CDATA[<p dir="auto">Morgan Stanley Reiterates Johnson &amp; Johnson (JNJ) Equal-Weight Recommendation <a href="https://www.proinvestor.com/investornyt/1019610/morgan-stanley-reiterates-johnson-amp-johnson-jnj-equal-weight-recommendation" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1019610/morgan-stanley-reiterates-johnson-amp-johnson-jnj-equal-weight-recommendation</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037868</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037868</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Sat, 22 Jul 2023 10:19:41 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Sat, 22 Jul 2023 10:17:52 GMT]]></title><description><![CDATA[<p dir="auto">Credit Suisse Maintains Johnson &amp; Johnson (JNJ) Neutral Recommendation <a href="https://www.proinvestor.com/investornyt/1019608/credit-suisse-maintains-johnson-amp-johnson-jnj-neutral-recommendation" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1019608/credit-suisse-maintains-johnson-amp-johnson-jnj-neutral-recommendation</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037869</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037869</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Sat, 22 Jul 2023 10:17:52 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Sat, 22 Jul 2023 10:15:58 GMT]]></title><description><![CDATA[<p dir="auto">JP Morgan Maintains Johnson &amp; Johnson (JNJ) Neutral Recommendation <a href="https://www.proinvestor.com/investornyt/1019609/jp-morgan-maintains-johnson-amp-johnson-jnj-neutral-recommendation" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1019609/jp-morgan-maintains-johnson-amp-johnson-jnj-neutral-recommendation</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037862</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037862</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Sat, 22 Jul 2023 10:15:58 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Tue, 18 Jul 2023 06:43:35 GMT]]></title><description><![CDATA[<p dir="auto">Lilly Says Its Alzheimer's Drug Significantly Slowed Cognitive And Functional Decline <a href="https://www.proinvestor.com/investornyt/1016637/lilly-says-its-alzheimers-drug-significantly-slowed-cognitive-and-functional-decline" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1016637/lilly-says-its-alzheimers-drug-significantly-slowed-cognitive-and-functional-decline</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037866</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037866</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 18 Jul 2023 06:43:35 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Tue, 18 Jul 2023 04:25:06 GMT]]></title><description><![CDATA[<p dir="auto">Cantor Fitzgerald Reiterates Lilly (LLY) Overweight Recommendation <a href="https://www.proinvestor.com/investornyt/1016612/cantor-fitzgerald-reiterates-lilly-lly-overweight-recommendation" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1016612/cantor-fitzgerald-reiterates-lilly-lly-overweight-recommendation</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037867</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037867</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 18 Jul 2023 04:25:06 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Tue, 18 Jul 2023 04:23:39 GMT]]></title><description><![CDATA[<p dir="auto">Schweizisk Genmab-partner opjusterer efter overbevisende kvartal <a href="https://www.proinvestor.com/investornyt/1016615/schweizisk-genmab-partner-opjusterer-efter-overbevisende-kvartal" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1016615/schweizisk-genmab-partner-opjusterer-efter-overbevisende-kvartal</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037861</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037861</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 18 Jul 2023 04:23:39 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juli 2023 on Mon, 17 Jul 2023 14:09:46 GMT]]></title><description><![CDATA[<p dir="auto">Eli Lilly med positivt resulat af Alzheimers-forsøg <a href="https://www.proinvestor.com/investornyt/1016270/eli-lilly-med-positivt-resulat-af-alzheimers-forsog" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1016270/eli-lilly-med-positivt-resulat-af-alzheimers-forsog</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037858</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037858</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 17 Jul 2023 14:09:46 GMT</pubDate></item></channel></rss>